In addition, the first-generation USP7 inhibitor P5091 induces apoptosis in multiple myeloma cells by promoting ubiquitination of MDM2 and MDMX, which in turn activates the p53 pathway and ultimately induces apoptosis. The gene discussed is TP53; the disease is plasma cell myeloma.